• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov26
Fed Pharma Zhongshan Branch's Cefoperazone Sodium and Sulbactam Sodium for Injection Passes Consistency Evaluation
09:12
Sep30
Federation Pharma's Innovative Drug UBT37034 Receives Clinical Trial Approval from National Medical Products Administration
08:38
Sep19
Zhongtai Securities Gives 'Buy' Rating to Fed Pharma
06:03
Sep17
CITIC Securities Initiates Coverage of FedPharma with a Strong Buy Rating
06:39
Sep9
Jefferies Raises Federal Pharma's Target Price to HKD 20 and Maintains Buy Rating
01:54
Sep3
Zhongtai International Publishes Report on Fed Pharma's H1 2025 Performance
04:26

Schedules & Filings

Schedules
Filings
Oct15
Distribution Plan(CST)

Cash dividend 0.175 HKD

Sep26
Distribution Plan(CST)

Cash dividend 0.175 HKD

Sep25
Distribution Plan(CST)

Cash dividend 0.175 HKD

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
01792
0.059
+103.45%
+0.030
02971
0.025
+78.57%
+0.011
08125
0.375
+44.23%
+0.115
01380
0.670
+38.14%
+0.185
01552
0.275
+36.14%
+0.073
08305
0.385
+35.09%
+0.100
01633
0.116
+27.47%
+0.025
00162
0.057
+26.67%
+0.012
01163
0.179
+26.06%
+0.037
02336
0.247
+24.12%
+0.048
View More